SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-063717
Filing Date
2019-11-14
Accepted
2019-11-14 08:05:31
Documents
3
Period of Report
2019-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-22803_18k.htm 8-K 30511
2 EX-99.1 a19-22803_1ex99d1.htm EX-99.1 69718
3 GRAPHIC g228031mmi001.jpg GRAPHIC 1766
  Complete submission text file 0001104659-19-063717.txt   103939
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 191216407
SIC: 2836 Biological Products, (No Diagnostic Substances)